Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Smith-Magenis syndrome chromosome region, candidate 2 (SMCR2)
- Target
- SMCR2
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
Smith-Magenis syndrome chromosome region, candidate 2 (SMCR2) is a long non-coding RNA gene (lncRNA), also referenced as TCONS_00025215, located in a genomic area associated with Smith-Magenis syndrome. There is currently no established function, protein product, or known association with disease phenotypes for SMCR2 specifically. It is not considered a therapeutic target, and its gene product is a non-protein-coding RNA of unknown functional significance[5][7][9]. Non-coding RNAs like SMCR2 can act in various regulatory capacities such as chromatin remodeling and transcriptional regulation, but there are no published studies or clinical data directly implicating SMCR2 in specific biological processes, molecular pathways, or diseases[8][10].
- Other names
- TCONS_00025215Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding)SMCR2
02
Biological functions
Unknown; like other lncRNAs, possible involvement in transcriptional or chromatin regulation, but no direct evidence is available for SMCR2 itself
03
Disease associations
Other (possible candidate gene in the region for Smith-Magenis syndrome, but not established or causative, and has no OMIM disease association)
Beyond the preview
Go deeper on Smith-Magenis syndrome chromosome region, candidate 2 (SMCR2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smith-Magenis syndrome chromosome region, candidate 2 (SMCR2).